For most people, TMS therapy does not ruin anything. It is a needle-free, medication-free depression treatment with one of the mildest side effect profiles of any option a psychiatrist can offer. But if you searched this exact phrase, you have probably already read a forum post or a review that scared you, and a generic reassurance is not going to fix that. So here is the direct answer: a small number of people do come out of TMS worse off, either because of a real side effect, a genuine non-response, or a mismatch between what they expected and what actually happened. This article walks through the honest version of all three, using published data rather than anecdotes, so you can decide with clear eyes.
What We Know
|
What people actually mean when they say TMS ruined their life
Search a phrase like this one and you will find a mix of very different experiences bundled under the same headline. It helps to separate them, because the honest answer and the fix are different for each.
- A physical side effect that was worse than expected, most often scalp pain, headache, or jaw discomfort during the first one to two weeks.
- No meaningful improvement after four to six weeks of daily sessions, which can feel like a loss of time, money, and hope even without any physical harm.
- A mood shift in the wrong direction, including irritability, agitation, or in rare cases a manic episode, most often in people with undiagnosed or under-treated bipolar disorder.
- Frustration with the schedule and cost, since a standard course means daily visits for four to six weeks, which is a real burden for people juggling work or caregiving.
The U.S. Food and Drug Administration keeps a public database of self-reported device complaints called MAUDE, and a search for NeuroStar TMS turns up a handful of first-person accounts describing worsened depression, new chronic pain, and significant disruption to daily life after treatment. These reports are worth taking seriously as lived experience. They are also unverified, self-selected, and cannot on their own establish that TMS caused what the person describes, since depression itself can worsen for unrelated reasons during any multi-week treatment window. Reading a few of these reports alongside the controlled trial data below gives a more honest picture than either source alone.
The real risk data, not the marketing version
Every treatment has a risk profile. Village TMS’s TMS program is upfront about it rather than pretending the treatment is risk-free, because that is what actually reduces the odds of a bad outcome.
Seizure, the rare but serious risk
Under ordinary clinical use, the estimated seizure risk from TMS is about 1 in 1,000 patients, or roughly 1 in 30,000 individual treatment sessions. That is comparable to, and in some analyses lower than, the seizure risk associated with several commonly prescribed antidepressants. Nearly every documented case has occurred in someone with an identifiable risk factor, most often a personal or family history of seizures, recent brain injury, heavy alcohol use, or severe sleep deprivation, which is why a thorough screening intake exists in the first place.
Mania or hypomania in people with bipolar disorder
TMS stimulates the brain, and in someone with undiagnosed or unstable bipolar disorder, that stimulation can occasionally trigger a manic or hypomanic episode. This is one of the more common threads behind a genuinely bad TMS experience, and it is also one of the most preventable, since a careful psychiatric history at intake is designed to catch it before treatment starts.
Hearing changes
TMS coils produce a clicking sound with each pulse, loud enough that hearing protection is standard practice during every session. Skipping that protection, even once, carries a small risk of temporary or, rarely, lasting changes in hearing.Who TMS is genuinely the wrong choice for
TMS is not a good fit for every person with depression, and a provider who tells you otherwise is not doing you any favors. The clearest reasons to think twice, or to have a longer conversation with a psychiatrist first, include:
- A personal history of seizures or a seizure disorder
- Non-removable magnetic or metal implants in or near the head, including certain aneurysm clips, cochlear implants, and stents
- Bipolar disorder that is not currently stabilized
- An expectation that TMS will work faster or more completely than the published response and remission rates actually predict
That last point matters more than it might seem. A patient who walks in expecting a guaranteed cure is far more likely to describe an honest partial response, or even a good one, as TMS having failed them.
A non-response is not the same as regret, and it is not the end of the road. Roughly 40 to 50 percent of patients do not reach a full response in a standard course, which is exactly why a real evaluation includes a plan for what happens next, whether that means adjusting the stimulation protocol, extending the course, layering in psychotherapy, or exploring a different treatment path such as Spravato or ketamine-assisted psychotherapy. The failure mode to watch for is not TMS itself, it is stopping the conversation with your provider the moment the first course ends.
How screening reduces the odds of a bad outcome
The risks above are almost all concentrated in patients who were not properly screened before starting. A thorough intake, including psychiatric history, current medications, and a physical screen for metal implants, along with individualized motor-threshold calibration at every visit, is what keeps the real-world numbers as low as the clinical trial numbers. This is the argument for choosing a provider that treats screening as a clinical step rather than a formality.
Call 646-817-2835 or contact us to book a free consultation.
